European Companies Search Engine
Capital: €126,024 Hrb17 Dec 2010 German Trade Register Announcements, Germany (16/12/2010)
Overview
Text
Seracell Pharma AG,
Rostock, Schillingallee 68, 18057 Rostock
. On the basis of the authorisation granted by amendments to the Articles of Association of January 31, 2008 and March 13, 2008, the increase in the share capital of up to EUR 3,500.00 decided by the Management Board on July 5, 2010 with the approval of the Supervisory Board of July 28, 2010, was carried out by a further EUR 1,724.00 to EUR 126,024.00. By resolution of the Supervisory Board of November 22, 2010, Section 4 of the Articles of Association (height and division of the share capital) has been amended. With the consent of the Supervisory Board, the Management Board is authorized to increase the share capital of the Company by up to a total of EUR 42,963.00 in cash and/or in-interest deposit by issuing new no-par value shares in the period up to April 3, 2013 (Authorized Capital I). The Management Board is authorized, with the consent of the Supervisory Board, to exclude the statutory subscription rights of shareholders in individual cases.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Seracell Pharma GmbH, Rostock, Germany.
